Market Overview Sun Pharmaceutical, India's largest drugmaker, is positioning itself in the lucrative anti-obesity and type 2 diabetes drug market. The company aims to launch its experimental drug within four to five years, capitalizing on the projected $150 billion global market by 2030. This long-term growth potential aligns with the recent bullish momentum in Sun Pharma’s stock price. Technical Analysis (15-Min Chart) All targets have been successfully hit, confirming a strong long trade setup. Entry Level: ₹1593.05 Stop-Loss (SL): ₹1587.55 (remained protected) Take Profit Levels (TPs): TP1 (₹1599.85) ✅ Achieved TP2 (₹1610.85) ✅ Achieved TP3 (₹1621.85) ✅ Achieved TP4 (₹1628.65) ✅ Final target reached Key Technical Indicators: RIsological Indicator: Bullish confirmation on the Risological indicator. Strong Trendline Support: The stock maintained higher lows, sustaining an uptrend. Volume Surge: Increased buying pressure fueled the move toward TP4. Trade Performance & Future Outlook Successful Execution: The trade played out perfectly, hitting all projected targets. Profit Booking Recommended: As all TPs are done, traders should consider locking in gains. Watch for Re-Entry: A pullback to ₹1610–₹1599 levels may offer a fresh buying opportunity. Sun Pharma's strong uptrend, backed by fundamental growth drivers, made this trade a high-conviction long setup. With the obesity drug pipeline in focus, the stock may continue to attract investor interest. Traders should wait for retracements before initiating new positions.
It feels we will settle much lower in the coming sessions ahead. Support current $ 85k and next after $ 83k and then GANN support $ 78k. I think the letter will be tested for a move to $ 65k area. Strategy SELL @ $ 85-90k and take profit near $ 66k for now.
NYSE:GS and the general financial services sector as a whole has faced extreme trauma over this past month. However, one that particularly stands out is the "bad guy" of the industry who has taken the equivalent to a roundhouse kick to the face, and the chart shows it. But does this mean that someone looking for a dip shouldn't pick up strong equity on a discount? I say no, lets be greedy while other are fearful just like that one guy said. Warren something... I don't really remember his name. Let's examine the numbers before we do the finance equivalent of astrology. This means that value investing and it's rather elementary techniques are going to give us some sort of indicator of a buy or a sell. Here's what you need to know. 1. Sachs has an attractive dividend yield of 2.14% ($11.50/share) and a gleaming dividend payout ratio (DPR) of 21.50%. 2. It is far from its high annual EPS sitting at 41.21 sliding from its high last December at 60.35. 3. It's price to earnings ratio (PE) is lounging nicely at 14.00 meaning we are at a generally cheap share price. This metric is what we're looking for. 4. Unfortunately, it has a rather higher price to book ratio (PB) at 1.64 which somewhat contradicts the PE ratio examined in #3. 5. Other metrics to keep in mind is an EV/EBITDA at 53.90 and a PEG at 16.23 which are both considered undesirable to investors. So as far as statistics are concerned, Goldman is sending some mixed signals making a decision difficult at the moment. This means we're going to have to examine the general sector sentiment and general outlook. Firstly, I'd like to point out Goldman's enterprise value. Sachs' EV is currently reported at 855.93 billion, 673 billion (78.63%) being debt (long term or short). This means NYSE:GS is a debt heavy company and we all know how debt works (the entity taking on the debt owes principal + interest). Well, this means that NYSE:GS is heavily going to be influenced by interest rates even considering their strong revenue. So, if we plan on interest rates being lowered long term (which I'm sure we all do), Goldman will be able to borrow from the Fed at a cheaper interest price while simultaneously owing account holders and bond holders less in interest (or APY yield for that matter). However, in the event that inflation runs wild and the Fed raises rates, NYSE:GS will face some turmoil along with the other commercial investment banks. Great, so now for the fun part. Let's see what the charts have to say about this and what it could be implying. Here is the 4H chart looking back into last October. https://www.tradingview.com/x/szBgqtG2/ As you can see, Goldman posted a sweet rally followed by our current pullback. However, we are being flashed with various bullish technical patterns and a strong explanation for the drop (even considering the tariffs threats and indices pullback). In summary, we are examining a stock in gradual freefall towards what appears to be several safety nets. On a psychological level, I find that most investors in the business of "smart money" wont let Goldman drop too low before they put their boot down. I also imagine this will happen pretty soon, but we need to hold the $540 price level. As far as the MACD is concerned, we are experiencing weakness from the buyers are the bears are clearly on offense. https://www.tradingview.com/x/8F8uJDKl/ And lastly, the GS implied volatility shows that options traders aren't pricing in anything particularly unusual, and the most usual movement for the market is to climb higher so that's good news. https://www.tradingview.com/x/irf8w2Wv/ So, what's the conclusion. In my humble opinion, I believe that Goldman Sachs' stock is trading too low to not buy. Financially, the company is not showing anything particularly concerning and may just need to show some strength before the mass cash chases this play. As of right now, I am long on NYSE:GS considering the financial statistics, general industry sentiment, and technical analysis which was used as an assistance tool. This trade could be last anywhere from 1 day to 1 year, but I am prepared to hold for much longer.
The manga by Tsuyoshi Takaki will soon have its very own TV anime adaptation. Alongside sharing the news that a Black Torch anime is officially in production at VIZ Media, IGN is exclusively able to reveal its first trailer.VIZ Media announced the Black Torch anime at its Emerald City Comic Con panel and the trailer below shows Jiro Azuma in his stealth uniform. He …
Get a sneak peek at the future of Disney Parks! SXSW's The Future of World-building at Disney Panel was filled with exciting details and teases of the future of Disney Parks, including how The Mandalorian and Grogu will be joining a new mission aboard Millennium Falcon: Smuggler's Run, that Imagineers will need to create a new type of ride vehicle …
The battle between PlayStation and Xbox may be past the finish line, but a new campaign awaits... PlayStation or Xbox? It’s the long-running question of the modern video game world. At one point or another in your life, you’ve almost certainly been a part of this debate. Maybe you’ve started a Reddit thread, or made a TikTok video, or struck up a heated chat between friends about …
Jack Quaid is irresistible as a pathetic man who can take a punch. Novocaine is in theaters on March 14, 2025.Edgar Wright made a name for himself with action comedies like Shaun of the Dead and Scott Pilgrim vs. the World – movies where normal, flawed dudes reluctantly kick ass and get the girl. But it’s been a while since we had a …
Blake Lively and Anna Kendrick spark up the chemistry again, this time against the stunning backdrop of coastal Italy. Another Simple Favor streams on Prime Video beginning May 1. This review is based on a screening at the 2025 SXSW Film and Television Festival.A sequel doesn’t have to be bigger, although many of them, including Another Simple Favor, choose to go this route. It doesn’t even have to be …
The Robert Pattinson/Bong Joon Ho movie has a bunch of differences from the sci-fi book that it's based on. Warning: Light spoilers follow for Mickey 17. Adaptation is an art and few have made it as wryly fun as Parasite director Bong Joon Ho has with his new film Mickey 17. Though the film follows the broad narrative strokes of Edward Ashton’s similarly darkly playful sci-fi novel Mickey7, …
Check out the first trailer for the anime adaptation of Black Torch, which is currently in production at VIZ Media. "A new era of ninja battles begins," the official synopsis reads. "Hailing from a long line of ninja, Jiro has been brought up by his grandfather in the ancient warrior art of the shinobi. Jiro also happens to be a particularly skilled communicator able to converse with the animal world. But life takes an abrupt turn thanks to a mysterious encounter in the forest with an injured black cat named Rago. Only, Rago's feline appearance is deceiving..."It turns out the “ordinary” cat is the stuff of mononoke legend–the Black Star of Doom! Swarming in the shadows are more mononoke, eager to exploit Rago’s uniquely immense powers. To fight back against the tide of dark spirits, the undercover Bureau of Espionage is poised to seek and destroy. Of course, everyone has their motives when it comes to Rago’s powers. But Jiro and Rago are ready. A shinobi clash between boy and mononoke is about to ignite!"